NEW YORK (GenomeWeb) – Genetic Technologies said today that it regained compliance with a listing requirement for continued listing on the Nasdaq, while the exchange has extended a deadline for the company to regain compliance with another requirement. 

In August Nasdaq sent a letter to Genetic Technologies informing the firm that it wasn't in compliance with a Nasdaq listing rule calling for a minimum $1 bid on the company's shares, and as a result the firm faced a possible delisting action. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.